Parvus Therapeutics Inc

Parvus Therapeutics Inc. is a privately held biopharmaceutical company developing the Navacims™ platform technology.

Biotechnology Research

Explore the company ↓Explore its lists ↓

Headquarters: South San Francisco, California, United StatesSource: RevenueBaseRetrieved October 13, 2026
Employee range: 11 to 50Source: RevenueBaseRetrieved October 13, 2026
Published list appearances: 3 supported appearances ↗Source: RevenueBase lists

The company at a glance

What does Parvus Therapeutics Inc do?

Parvus is advancing proprietary drug candidates for multiple autoimmune indications through preclinical development and into the clinical stage. Parvus’s stated approach is Navacim-directed immune regulation, aiming to avoid the non-specific immune suppression associated with current therapies.

Based on the company’s public LinkedIn information, supplied through RevenueBase.

Explore the business in context

Company lists.

Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.

#17OF 24

South San Francisco

Immunotherapy biotech companies

Snapshot: September 14, 2026

↗

#23OF 25

South San Francisco

Immunotherapy companies

Snapshot: September 19, 2026

↗

#25OF 25

United States

Autoimmune drug manufacturers

Snapshot: September 29, 2026

↗

Positions describe ordering within each source list. See how lists are built ↗

Share your recognition

Embeddable award for your website

BADGE PREVIEW

Open the published source list.

Parvus Therapeutics Inc

#17 Immunotherapy biotech companies

Snapshot: September 14, 2026

Display size

Download SVG

Copy this code into your website

<a href="https://revenuebase.ai/companies/immunotherapy-biotech-companies/united-states/south-san-francisco" target="_blank" rel="nofollow noopener">
  <img src="https://revenuebase.ai/companies/profiles/parvustx/recognition-companies-immunotherapy-biotech-companies-united-states-south-san-francisco-20260915-75a641e3605bdb4112d271ab1369ce34ad2825a373ba2bdd7bd80f46482b4c72.svg" alt="Parvus Therapeutics Inc listed #17 on Immunotherapy biotech companies, September 14, 2026" width="220" height="319" style="max-width:100%;height:auto;" />
</a>

View live list ↗

Sources & data notes.

RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026, September 19, 2026 and September 29, 2026. How the company lists are built.

Help keep this profile accurate

Something changed?

Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.

Request an update ↗

Find your next account

One company is just the start.

Explore more companies by name, headquarters and business focus.

Explore company profiles →